Major and trace elements in lithogenesis

Central European Journal of Urology

Volumn 64, Issue 2, 2011, Pages 58-61

  Słojewski, Marcin ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Pathogenesis; Trace elements; Urinary stone

Indexed keywords

EID: 79960686650     PISSN: 20804806     EISSN: 20804873     Source Type: Journal    
DOI: 10.5173/ceju.2011.02.art1     Document Type: Review

References (57)

1. Ramello A, Vitale C, Marangella M: Epidemiology of nephrolithiasis. J Nephrol 2000; Suppl. 3: 45-50.
2. Pak CY: Kidney stones. Lancet 1998; 351: 1797-1801.
3. Ryall RL, Harnett RM, Marshall VR: The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 1981; 112: 349-356.
4. Marangella M, Bagnis C, Bruno M et al: Crystallization inhibitors in the pathophysiology and treatment of nephrolithiasis. Urol Int 2004; 72; Suppl. 1: 6-10.
5. Hess B, Zipperle L, Jaeger P: Citrate and calcium effects on Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregation. Am J Physiol 1993; 265: 784-791.
6. Trinchieri A, Mandressi A, Luongo P et al: The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers. Br J Urol 1991; 67: 230-236.
7. Moe OW: Kidney stones: pathophysiology and medical management. Lancet 2006; 367: 333-344.
8. Atakan IH, Kaplan M, Seren G et al: Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients. Int Urol Nephrol 2007; 39: 351-356.
9. Parsons J: Zinc phosphate identified as a constituent of urinary calculi. Science 1953; 118: 217-218.
10. Bazin D, Chevallier P, Matzen G et al: Heavy elements in urinary stones. Urol Res 2007; 35: 179-184.
11. Joost J, Tessadri R: Trace element investigations in kidney stone patients. Eur Urol 1987; 13: 264-270.
12. Perk H, Serel TA, Kosar A et al: Analysis of the trace element contents of inner nucleus and outer crust parts of urinary calculi. Urol Int 2002; 68: 286-290.
13. Oka T, Yoshioka T, Koide T et al: Role of magnesium in the growth of calcium oxalate monohydrate and calcium oxalate dihydrate crystals. Urol Int 1987; 42: 89-93.
14. Durak I, Kilic Z, Sahin A, Akpoyraz M: Analysis of calcium, iron, copper and zinc contents of nucleus and crust parts of urinary calculi. Urol Res 1992; 20: 23-26.
15. Durak I, Kilic Z, Perk H et al: Iron, copper, cadmium, zinc and magnesium contents of urinary tract stones and hair from men with stone disease. Eur Urol 1990; 17: 243-247.
16. Trinchieri A, Castelnuovo C, Lizzano R, Zanetti G: Calcium stone disease: a multiform reality. Urol Res 2005; 33: 194-198.
17. Munoz JA, Valiente M: Effects of trace metals on the inhibition of calcium oxalate crystallization. Urol Res 2005; 33: 267-272.
18. Hofbauer J, Steffan I, Höbarth K et al: Trace elements and urinary stone formation: new aspects of the pathological mechanism of urinary stone formation. J Urol 1991; 145: 93-96.
19. Rodgers A, Barbour L, Pougnet B et al: Urinary element concentrations in kidney stone formers and normal controls: the week-end effect. J Trace Elem Electrolytes Health Dis 1994; 8: 87-91.
20. Komleh K, Hada P, Pendse AK, Singh PP: Zinc, copper and manganese in serum, urine and stones. Int Urol Nephrol 1990; 22: 113-118.
21. Bird ED, Thomas WC: Effect of various metals on mineralization in vitro. Proc Soc Exp Biol Med 1963; 112: 640-643.
22. Meyer JL, Angino EE: The role of trace metals in calcium urolithiasis. Invest Urol 1977; 14: 347-350.
23. Welshman SG, McGeown MG: A quantitative investigation of the effects on the growth of calcium oxalate crystals on potential inhibitors. Br J Urol 1972; 44: 677-680.
24. Sutor DJ: Growth studies of calcium oxalates in the presence of various ions and compounds. Br J Urol 1969; 41: 171-178.
25. Scott R, East BW, Janczyszyn J et al: Concentration of some minor and trace elements in urinary tract stones: a preliminary study. Urol Res 1980; 8: 167-169
26. Słojewski M, Czerny B, Safranow K et al: Microelements in stones, urine, and hair of stone formers: a new key to the puzzle of lithogenesis? Biol Trace Elem Res 2010; 137: 301-316.
27. Durak I, Kilic Z, Sahin A, Akpoyraz M: Analysis of calcium, iron, copper and zinc contents of nucleus and crust parts of urinary calculi. Urol Res 1992; 20: 23-26.
28. Durak I, Kilic Z, Perk H et al: Iron, copper, cadmium, zinc and magnesium contents of urinary tract stones and hair from men with stone disease. Eur Urol 1990; 17: 243-247.
29. Escott-Stump S: Nutritional review. In: Nutrition and diagnosis-related care. Philadelphia: Wolters Kluwer, Lippincot Williams and Wilkins, 2007, pp. 842-862.
30. Kohri K, Garside J, Blacklock NJ: The role of magnesium in calcium oxalate urolithiasis. Br J Urol 1988; 61: 107-112.
31. Robertson WG: Measurement of ionized calcium in biological fluids. Clin Chim Acta 1969; 24: 149-157.
32. Kohri K, Garside J, Blacklock NJ: The role of magnesium in calcium oxalate urolithiasis. Br J Urol 1988; 61: 107-115.
33. Li MK, Blacklock NJ, Garside J: Effects of magnesium on calcium oxalate crystallization. J Urol 1985; 133: 123-125.
34. Schmiedl A, Schwille PO: Magnesium status in idiopathic calcium urolithiasis-an orientational study in younger males. Eur J Clin Chem Clin Biochem 1996; 34: 393-400.
35. Lieu PT, Heiskala M, Peterson PA, Yang Y: The roles of iron in health and disease. Mol Asp Med 2001; 22: 1-87.
36. Fraker PJ, Telford WG: A reappraisal of the role of zinc in life and death decisions of cells. Proc Soc Exp Biol Med 1997; 215: 229-236.
37. Hofbauer J, Steffan I, Höbarth K et al: Trace elements and urinary stone formation: new aspects of the pathological mechanism of urinary stone formation. J Urol 1991; 145: 93-96.
38. Kjellström T, Evrin PE, Rahnster B: Dose-response analysis of cadmiuminduced tubular proteinuria: a study of urinary beta2-microglobulin excretion among workers in a battery factory. Environ Res 1977; 13: 303-317.
39. Iwata K, Saito H, Moriyama M, Nakano A: Renal tubular function after reduction of environmental cadmium exposure: a ten-year follow-up. Arch Environ Health 1993; 48: 157-163.
40. Lyon TD, Aughey E, Scott R, Fell GS: Cadmium concentrations in human kidney in the UK: 1978-1993. J Environ Monit 1999; 1: 227-231.
41. Scott R, Paterson PJ, Burns R et al: The effects of treatment on the hypercalciuria of chronic cadmium poisoning. Urol Res 1979; 7: 285-289.
42. Hunt CD, Herbel JL, Nielsen FH: Metabolic responses of postmenopausal women to supplemental dietary boron and aluminum during usual and low magnesium intake: boron, calcium, and magnesium absorption and retention and blood mineral concentrations. Am J Clin Nutr 1997; 65: 803-813.
43. Gołabek B, Hozyasz KK, Ruszczyńska A et al: Wydalanie pierwiastków śladowych z moczem u chorych z kamica{ogonek} cystynowa{ogonek} [Urinary trace elements excrection in patients with cystine calculosis]. Pol Merkur Lek 2004; 17; 435-437.
44. Huel G, Fréry N, Takser L et al: Evolution of blood lead levels in urban French population (1979-1995). Rev Epidemiol Sante Publique 2002; 50: 287-295.
45. Barceloux DG: Vanadium. J Toxicol Clin Toxicol 1993; 37: 265-278.
46. Abboud IA: Concentration effect of trace metals in Jordanian patients of urinary calculi. Environ Geochem Health 2008; 30: 11-20.
47. Boosalis MG: The role of selenium in chronic disease. Nutr Clin Pract 2008; 23: 152-160.
48. Lippman SM, Klein EA, Goodman PJ: Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009; 301: 39-51.
49. Stranges S, Marshall JR, Natarajan R: Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 2007; 147: 217-223.
50. Sakly R, Chaouch A, El Hani A, Najjar MF: Effects of intraperitoneally administered vitamin E and selenium on calcium oxalate renal stone formation: experimental study in rat. Ann Urol (Paris) 2003; 37: 47-50.
51. Ponnapakkam T, Iszard M, Henry-Sam G: Effects of oral administration of manganese on the kidneys and urinary bladder of Sprague-Dawley rats. Int J Toxicol 2003; 22: 227-232.
52. Turgut M, Unal I, Berber A et al: The concentration of Zn, Mg and Mn in calcium oxalate monohydrate stones appears to interfere with their fragility. Urol Res 2008; 36: 31-38.
53. Nagy Z, Szabó E, Kelenhegyi M: Spektralanalytische Untersuchung von Nierensteien auf metallische Spurenelemente. Z Urol 1963; 56: 185-190.
54. Eusebio E, Elliot JS: Effect of trace metals on the crystallization of calcium oxalate. Invest Urol 1967; 4: 431-435.
55. Levinson AA, Nosal M, Davidman M et al: Trace elements in kidney stones from three areas in the United States. Invest Urol 1978; 15: 270-274.
56. Rangnekar GV, Gaur MS: Serum and urinary zinc levels in urolithiasis. Br J Urol 1993; 71: 527-529.
57. Küpeli S, Arikan N, Durak I et al: Efficiency of extracorporeal shockwave lithotripsy on calcium-oxalate stones: role of copper, iron, magnesium and zinc concentrations on disintegration of the stones. Eur Urol 1993; 23: 409-412.